SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 09/03/15 -- (OTCQB: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura long-term drug delivery technology, announced today that Sunil Bhonsle, president, will ...
↧